BR, W., V, V., S, Z., BA, M., HR, S., & RM, S. (2025). Capacity for compensatory cyclin D2 response confers trametinib resistance in canine mucosal melanoma. BioRxiv : the preprint server for biology. https://doi.org/10.1101/2025.04.24.650512
Chicago Style (17th ed.) CitationBR, Wei, Verdi V, Zhang S, Mock BA, Shive HR, and Simpson RM. "Capacity for Compensatory Cyclin D2 Response Confers Trametinib Resistance in Canine Mucosal Melanoma." BioRxiv : The Preprint Server for Biology 2025. https://doi.org/10.1101/2025.04.24.650512.
MLA (9th ed.) CitationBR, Wei, et al. "Capacity for Compensatory Cyclin D2 Response Confers Trametinib Resistance in Canine Mucosal Melanoma." BioRxiv : The Preprint Server for Biology, 2025, https://doi.org/10.1101/2025.04.24.650512.